Imaging renal cell carcinoma with ultrasonography, CT and MRI

  • Leveridge M
  • Bostrom P
  • Koulouris G
 et al. 
  • 7


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


The increased use of abdominal imaging techniques for a variety of indications has contributed to more-frequent detection of renal cell carcinoma (RCC). Ultrasonography has been used to characterize the solid versus cystic nature of renal masses. This modality has limitations, however, in further characterization of solid tumors and in staging of malignancy, although contrast-enhanced ultrasonography has shown promise. Cross-sectional imaging with multiplanar reconstruction capability via CT or MRI has become the standard-bearer in the diagnosis, staging and surveillance of renal cancers. The use of specific protocols and the exploitation of different imaging characteristics of RCC subtypes, including variations in contrast agent timing, MRI weighting and digital subtraction, have contributed to this diagnostic capability. Cystic renal masses are a special case, evaluation of which can require multiple imaging modalities. Rigorous evaluation of these lesions can provide information that is crucial to prediction of the likelihood of malignancy. Such imaging is not without risk, however, as radiation from frequent CT imaging has been implicated in the development of secondary malignancies, and contrast agents for CT and MRI can pose risks, particularly in patients with compromised renal function. © 2010 Macmillan Publishers Limited. All rights reserved.

Author-supplied keywords

  • acetylcysteine
  • alpha interferon
  • angiogenesis
  • antioxidant
  • cancer chemotherapy
  • cancer diagnosis
  • cancer staging
  • clinical practice
  • clinical protocol
  • computer assisted emission tomography
  • computer assisted tomography
  • contrast enhancement
  • contrast induced nephropathy
  • contrast medium
  • diagnostic accuracy
  • diagnostic imaging
  • differential diagnosis
  • drug contraindication
  • drug fatality
  • drug hypersensitivity
  • drug safety
  • echo contrast medium
  • echography
  • fluorodeoxyglucose f 18
  • gadolinium
  • hemofiltration
  • human
  • hydration
  • image reconstruction
  • iodinated contrast medium
  • kidney carcinoma
  • kidney cyst
  • kidney function
  • microbubble
  • monoclonal antibody
  • multidetector computed tomography
  • multiple cycle treatment
  • nephrectomy
  • nephrotoxicity
  • nonhuman
  • nuclear magnetic resonance imaging
  • nuclear magnetic resonance imaging agent
  • overall survival
  • patient monitoring
  • postoperative period
  • practice guideline
  • priority journal
  • progression free survival
  • protein tyrosine kinase inhibitor
  • radiation dose
  • radiation exposure
  • radiofrequency ablation
  • radiologist
  • review
  • second cancer
  • sorafenib
  • spiral computer assisted tomography
  • sunitinib
  • treatment response
  • tumor volume
  • ultrasound
  • unspecified side effect
  • vasodilator agent

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • M J Leveridge

  • P J Bostrom

  • G Koulouris

  • A Finelli

  • N Lawrentschuk

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free